Literature DB >> 22932992

Trajectory of functional recovery after hospital discharge for subarachnoid hemorrhage.

Babak B Navi1, Hooman Kamel, J Claude Hemphill, Wade S Smith.   

Abstract

BACKGROUND: Although there are extensive data on long-term disability after subarachnoid hemorrhage (SAH), there are few data on the trajectory of functional recovery after hospital discharge.
METHODS: From October 2009 to April 2010, we prospectively followed consecutive patients with non-traumatic SAH discharged from a university hospital. Modified Rankin Scale (mRS) scores were calculated at discharge from chart review and at 6 months by standardized telephone interview. Good functional status was defined as a mRS score of 0-2, and poor status as an mRS score of 3-6. Descriptive statistics were used to assess the trajectory of functional recovery and determine the proportion of patients whose functional status improved from poor to good.
RESULTS: Among 52 patients with non-traumatic SAH (79 % aneurysmal) who were discharged alive, most (71 %) were discharged home. Median (IQR) mRS score was 3 (2-4) at discharge and 2 (1-2) at 6 months. Some functional recovery (any improvement in mRS score) was seen in most patients (83 %; 95 % CI, 72-93 %). Of the 28 patients with poor functional status at discharge, 16 (57 %) improved to good functional status at 6 months. All patients with Hunt-Hess grade 4 or 5 hemorrhages (n = 14) had poor functional status at discharge, but half (95 % CI, 20-80 %) recovered to a good functional status at 6 months.
CONCLUSIONS: Although our sample size is small, our findings suggest that a substantial proportion of patients with SAH who are disabled at discharge go on to regain functional independence within 6 months.

Entities:  

Mesh:

Year:  2012        PMID: 22932992     DOI: 10.1007/s12028-012-9772-3

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  25 in total

1.  Health-related quality of life in patients with subarachnoid haemorrhage.

Authors:  Bernhard Meyer; Florian Ringel; Yaroslav Winter; Annika Spottke; Nadir Gharevi; Judith Dams; Monika Balzer-Geldsetzer; Ines K Mueller; Thomas Klockgether; Johannes Schramm; Horst Urbach; Richard Dodel
Journal:  Cerebrovasc Dis       Date:  2010-08-18       Impact factor: 2.762

2.  Interobserver agreement for the assessment of handicap in stroke patients.

Authors:  J C van Swieten; P J Koudstaal; M C Visser; H J Schouten; J van Gijn
Journal:  Stroke       Date:  1988-05       Impact factor: 7.914

3.  Surgical risk as related to time of intervention in the repair of intracranial aneurysms.

Authors:  W E Hunt; R M Hess
Journal:  J Neurosurg       Date:  1968-01       Impact factor: 5.115

Review 4.  Long-term outcomes of patients with aneurysmal subarachnoid haemorrhage.

Authors:  Gabriel J E Rinkel; Ale Algra
Journal:  Lancet Neurol       Date:  2011-04       Impact factor: 44.182

5.  Predictors of global cognitive impairment 1 year after subarachnoid hemorrhage.

Authors:  Mellanie V Springer; J Michael Schmidt; Katja E Wartenberg; Jennifer A Frontera; Neeraj Badjatia; Stephan A Mayer
Journal:  Neurosurgery       Date:  2009-12       Impact factor: 4.654

6.  Clinical course of spontaneous subarachnoid hemorrhage: a population-based study in King County, Washington.

Authors:  W T Longstreth; L M Nelson; T D Koepsell; G van Belle
Journal:  Neurology       Date:  1993-04       Impact factor: 9.910

7.  Prediction of delayed cerebral ischemia, rebleeding, and outcome after aneurysmal subarachnoid hemorrhage.

Authors:  A Hijdra; J van Gijn; N J Nagelkerke; M Vermeulen; H van Crevel
Journal:  Stroke       Date:  1988-10       Impact factor: 7.914

8.  Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis.

Authors:  Dennis J Nieuwkamp; Larissa E Setz; Ale Algra; Francisca H H Linn; Nicolien K de Rooij; Gabriël J E Rinkel
Journal:  Lancet Neurol       Date:  2009-06-06       Impact factor: 44.182

9.  Recovery and rehabilitation following subarachnoid haemorrhage. Part I: Outcome after inpatient rehabilitation.

Authors:  M L Dombovy; J Drew-Cates; R Serdans
Journal:  Brain Inj       Date:  1998-06       Impact factor: 2.311

10.  The effect of window rooms on critically ill patients with subarachnoid hemorrhage admitted to intensive care.

Authors:  Hannah Wunsch; Hayley Gershengorn; Stephan A Mayer; Jan Claassen
Journal:  Crit Care       Date:  2011-03-03       Impact factor: 9.097

View more
  5 in total

Review 1.  What is new in neurocritical care: 2012.

Authors:  Nino Stocchetti
Journal:  Intensive Care Med       Date:  2013-03       Impact factor: 17.440

Review 2.  Childhood basilar artery occlusion: a report of 5 cases and review of the literature.

Authors:  Mahesh Chikkannaiah; Warren D Lo
Journal:  J Child Neurol       Date:  2013-05-13       Impact factor: 1.987

3.  Response of brain oxygen to therapy correlates with long-term outcome after subarachnoid hemorrhage.

Authors:  Leif-Erik Bohman; Jared M Pisapia; Matthew R Sanborn; Suzanne Frangos; Elsa Lin; Monisha Kumar; Soojin Park; W Andrew Kofke; Michael F Stiefel; Peter D LeRoux; Joshua M Levine
Journal:  Neurocrit Care       Date:  2013-12       Impact factor: 3.210

4.  Anemia prevalence and incidence and red blood cell transfusion practices in aneurysmal subarachnoid hemorrhage: results of a multicenter cohort study.

Authors:  Shane W English; Michaël Chassé; Alexis F Turgeon; François Lauzier; Donald Griesdale; Allan Garland; Dean Fergusson; Ryan Zarychanski; Carl van Walraven; Kaitlyn Montroy; Jennifer Ziegler; Raphael Dupont-Chouinard; Raphaëlle Carignan; Andy Dhaliwal; Ranjeeta Mallick; John Sinclair; Amélie Boutin; Giuseppe Pagliarello; Alan Tinmouth; Lauralyn McIntyre
Journal:  Crit Care       Date:  2018-07-04       Impact factor: 9.097

Review 5.  Aneurysmal Subarachnoid Hemorrhage: the Last Decade.

Authors:  Sean N Neifert; Emily K Chapman; Michael L Martini; William H Shuman; Alexander J Schupper; Eric K Oermann; J Mocco; R Loch Macdonald
Journal:  Transl Stroke Res       Date:  2020-10-19       Impact factor: 6.829

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.